The Patent Finder

Tropomyosin-Related Kinase (TRK) Inhibitors

Genzyme Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 62/040,750, filed Aug 22, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,067,914Tropomyosin-Related Kinase (TRK) Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 9,174,986Tropomyosin-Related Kinase (TRK) Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 9,611,265Tropomyosin-Related Kinase (TRK) Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 10,166,239Tropomyosin-Related Kinase (TRK) Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 11,406,644Tropomyosin-Related Kinase (TRK) Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 11,878,024Tropomyosin-Related Kinase (trk) Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
US 12,318,392Tropomyosin-Related Kinase (trk) Inhibitors
In force
 · High confidence
Genzyme CorporationIn force
High confidence
Application 16/194,696Tropomyosin-Related Kinase (TRK) Inhibitors
Abandoned
Abandoned Oct 9, 2020
Genzyme CorporationAbandonedAbandoned Oct 9, 2020
Application 19/223,215Tropomyosin-Related Kinase (TRK) Inhibitors
Pending
Not granted
Genzyme CorporationPendingNot granted
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Genzyme Corporation.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited